172 related articles for article (PubMed ID: 9205789)
1. Effects of systemic administration of 2-(4-phenyl-piperidino)-cyclohexanol (vesamicol) and an organophosphate DDVP on the cholinergic system in brain regions of rats.
Kobayashi H; Watanabe T; Yasufuku T; Suzuki T; Saitoh S; Takeno K
Brain Res Bull; 1997; 43(1):17-23. PubMed ID: 9205789
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic system of brain tissue in rats poisoned with the organophosphate, 0,0-dimethyl 0-(2,2-dichlorovinyl) phosphate.
Kobayashi H; Yuyama A; Chiba K
Toxicol Appl Pharmacol; 1986 Jan; 82(1):32-9. PubMed ID: 3945941
[TBL] [Abstract][Full Text] [Related]
3. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).
Roghani A; Carroll PT
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018
[TBL] [Abstract][Full Text] [Related]
4. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
Vizi ES
Br J Pharmacol; 1989 Nov; 98(3):898-902. PubMed ID: 2590773
[TBL] [Abstract][Full Text] [Related]
5. Effects of single or repeated administration of a carbamate, propoxur, and an organophosphate, DDVP, on jejunal cholinergic activities and contractile responses in rats.
Kobayashi H; Sato I; Akatsu Y; Fujii S; Suzuki T; Matsusaka N; Yuyama A
J Appl Toxicol; 1994; 14(3):185-90. PubMed ID: 8083479
[TBL] [Abstract][Full Text] [Related]
6. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
[TBL] [Abstract][Full Text] [Related]
7. Suppression of in vivo neostriatal acetylcholine release by vesamicol: evidence for a functional role of vesamicol receptors in brain.
Marien MR; Richard JW; Allaire C; Altar CA
J Neurochem; 1991 Dec; 57(6):1878-83. PubMed ID: 1658227
[TBL] [Abstract][Full Text] [Related]
8. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
Altar CA; Marien MR
Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of potassium-stimulated acetylcholine release from rat brain cortical slices by two high-affinity analogs of vesamicol.
Leão RM; Gomez MV; Collier B; Prado MA
Brain Res; 1995 Dec; 703(1-2):86-92. PubMed ID: 8719619
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of beta-bungarotoxin on the acetylcholine system in different brain areas of the rat.
Gulya K; Budai D; Kása P; Rakonczay Z
J Neurochem; 1984 Jul; 43(1):112-9. PubMed ID: 6726239
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic administration of DDVP (dichlorvos) on distribution of brain acetylcholine in rats.
Kobayashi H; Yuyama A; Imajo S; Matsusaka N
J Toxicol Sci; 1980 Nov; 5(4):311-9. PubMed ID: 7218377
[TBL] [Abstract][Full Text] [Related]
12. Transmitter packaging at frog neuromuscular junctions exposed to anticholinesterases; the role of second-stage acetylcholine loading.
Naves LA; Van der Kloot W
J Neurophysiol; 1996 Oct; 76(4):2614-25. PubMed ID: 8899632
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons.
Auld DS; Mennicken F; Day JC; Quirion R
J Neurochem; 2001 Apr; 77(1):253-62. PubMed ID: 11279281
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of endogenous acetylcholine release from primary septal cultures.
Auld DS; Day JC; Mennicken F; Quirion R
J Pharmacol Exp Ther; 2000 Feb; 292(2):692-7. PubMed ID: 10640307
[TBL] [Abstract][Full Text] [Related]
15. Brain regional acetylcholinesterase activity and muscarinic acetylcholine receptors in rats after repeated administration of cholinesterase inhibitors and its withdrawal.
Kobayashi H; Suzuki T; Sakamoto M; Hashimoto W; Kashiwada K; Sato I; Akahori F; Satoh T
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):151-61. PubMed ID: 17188317
[TBL] [Abstract][Full Text] [Related]
16. Effect of 2-(4-phenylpiperidino)cyclohexanol (AH 5183) on the veratridine-induced increase in acetylcholine synthesis by rat hippocampal tissue.
Carroll PT; Ivy MT
J Neurochem; 1988 Sep; 51(3):808-19. PubMed ID: 3411328
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of the readily releasable pool of acetylcholine from a sympathetic ganglion by tityustoxin in the presence of vesamicol.
Prado MA; Gomez MV; Collier B
J Neurochem; 1992 Aug; 59(2):544-52. PubMed ID: 1629727
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the vesamicol receptor in cholinergic synaptic vesicles by acetylcholine and an endogenous factor.
Noremberg K; Parsons SM
J Neurochem; 1989 Mar; 52(3):913-20. PubMed ID: 2537382
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
Prior C; Marshall IG; Parsons SM
Gen Pharmacol; 1992 Nov; 23(6):1017-22. PubMed ID: 1487110
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma.
Lau JK; Brown KC; Thornhill BA; Crabtree CM; Dom AM; Witte TR; Hardman WE; McNees CA; Stover CA; Carpenter AB; Luo H; Chen YC; Shiflett BS; Dasgupta P
Cancer Res; 2013 Feb; 73(4):1328-39. PubMed ID: 23222296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
